-
AIDX share price: currently unavailable. Sorry, we currently don't have enough data to create an insight.
-
Price change
The price of AIDX shares has increased $0.01 since the market last closed. This is a 5.03% rise.
-
Closed at $0.20.
The stock has since dropped $0.01 in after-hours trading.
Key terms
About AIDX
20/20 Biolabs, Inc. engages in development and commercialization of proteomics product line. Its products include One Test, PAULA's Test and BioCheck Suspisious Powder Testing Kit. The company was founded by Jonathan Cohen in May 2000 and is headquartered in Gaithersburg, MD.
-
Market cap: $2.62M
A market capitalization up to $300 million places AIDX in the micro-capitalization category.
Key terms
Smart score
Latest AIDX news
AIDX Financials
-
Total revenue: $2.04M (1Y), $730.57K (Q2)
Total Revenue increased 16.71% since last year and increased 106.74% since last quarter.
-
Net income: -$3.74M (1Y), -$1.51M (Q2)
Net Income increased 32.65% since last year and increased 30.74% since last quarter.
-
Earnings per share: -$0.36 (1Y), -$0.22 (Q2)
EPS increased 69.14% since last year and decreased 10.64% since last quarter.
Key terms
AIDX Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
AIDX Competitors
-
How competitors are chosen
AIDX's competitors are included in the Health Services sector and Medical/Nursing Services group
-
Market cap: $2.62M
A market capitalization up to $300 million places AIDX in the micro-capitalization category.
